---
title: "Trending peptides and research this month"
url: https://humanpeptides.fyi/trending
site: humanpeptides.fyi
last_reviewed: 2026-10-11
---


# Trending now.

> humanpeptides.fyi makes no claims of its own. Every benefit, side effect, nickname and quote reports what a cited source says, with its link. Not medical advice.

## Top 10 trending peptides as of October 11, 2026

Most discussed in the last 30 days, counted from Reddit and YouTube. Counted and linked, not endorsed.

1. [GHK-Cu](https://humanpeptides.fyi/peptides/ghk-cu): 9 public posts and videos
2. [Retatrutide](https://humanpeptides.fyi/peptides/retatrutide): 5 public posts and videos
3. [IGF-1 LR3](https://humanpeptides.fyi/peptides/igf-1-lr3): 7 public posts and videos
4. [Tirzepatide](https://humanpeptides.fyi/peptides/tirzepatide): 6 public posts and videos
5. [AHK-Cu](https://humanpeptides.fyi/peptides/ahk-cu): 8 public posts and videos
6. [Tesamorelin](https://humanpeptides.fyi/peptides/tesamorelin): 7 public posts and videos
7. [BPC-157](https://humanpeptides.fyi/peptides/bpc-157): 6 public posts and videos
8. [Glutathione](https://humanpeptides.fyi/peptides/glutathione): 7 public posts and videos
9. [SS-31](https://humanpeptides.fyi/peptides/ss-31): 7 public posts and videos
10. [CJC-1295 + Ipamorelin](https://humanpeptides.fyi/peptides/cjc-1295-ipamorelin): 6 public posts and videos

## Top 10 trending peptide research items as of October 11, 2026

Newest headlines from the [Peptide News Network research feed](https://peptidenewsnetwork.com/category/research/); not reviewed by humanpeptides.fyi.

1. [Scorpion venom peptides: what the research shows](https://peptidenewsnetwork.com/articles/scorpion-venom-peptides-research/) (September 20, 2026): Scorpion venom peptides are drawing fresh scientific attention for liver and inflammatory disease. Here is what preclinical studies have found so far.
2. [LL-37 Levels Reflect Sleep Quality in Obstructive Sleep Apnea](https://peptidenewsnetwork.com/articles/llt-37-sleep-osa/) (September 18, 2026): Observational study links plasma LL-37 levels to sleep quality in obstructive sleep apnea, suggesting pLL-37 as a potential biomarker of disease severity and immune vulnerability.
3. [Systematic ranking of peptide drugs in new review](https://peptidenewsnetwork.com/articles/systematic-ranking-peptide-drugs/) (September 17, 2026): An updated systematic review grades peptide therapeutics across functional and evidence-based classes, offering comparative effectiveness insights in peptide drug science.
4. [First-in-class non-GLP-1 peptide advances metabolic therapy](https://peptidenewsnetwork.com/articles/first-non-glp1-peptide/) (September 15, 2026): A first-in-class non-GLP-1 peptide - AT7687, a GIPR antagonist - has entered public awareness, marking a mechanistic departure within metabolic peptide therapeutics.
5. [Scorpion Peptides: Antiviral Research Explained](https://peptidenewsnetwork.com/articles/scorpion-peptides-antiviral-research/) (September 14, 2026): A new review maps how scorpion peptides disrupt viral entry and replication across preclinical models. Here is what the antiviral research actually shows.
6. [AmyP53 Nasal Spray: Nose-to-Brain Delivery Tested](https://peptidenewsnetwork.com/articles/amyp53-nasal-spray-brain-delivery/) (September 13, 2026): A new study tested an AmyP53 nasal spray device for nose-to-brain delivery in Alzheimer's and Parkinson's disease models. Here's what the preclinical data show.
7. [Case Report: Online-Purchased Retatrutide Harms](https://peptidenewsnetwork.com/articles/online-retatrutide-case/) (September 10, 2026): Clinical case report describes complications after a patient self-administered online-purchased retatrutide, raising safety concerns over unregulated peptide use.
8. [Calreticulin Mutations: A Peptide Immunotherapy Target](https://peptidenewsnetwork.com/articles/calreticulin-mutations-immunotherapy-target/) (September 6, 2026): New research shows calreticulin mutations create a tumor-specific peptide target in blood cancers. Here's what the preclinical data reveal.
9. [Bioactive Peptides: Gut Survival Explained](https://peptidenewsnetwork.com/articles/bioactive-peptides-gut-survival/) (August 31, 2026): New research maps how bioactive peptides survive digestion, cross gut walls, and reach circulation - and why most never make it that far.
10. [RGD Mimics and Fibrosis: New Preclinical Data](https://peptidenewsnetwork.com/articles/rgd-mimics-fibrosis-preclinical-data/) (August 24, 2026): RGD mimics show anti-fibrotic effects in mice. Plus: nasal peptide delivery for brain injury and cancer peptide combos. Research digest.